SCP Electronic Forum: Comments and Documents (SCP/38)

Statements submitted by SCP/38 participants

General statement

Country/Observer Document(s)
CACEEC (Group of Central Asian, Caucasus, and Eastern European Countries) [PDF]
GRULAC (Group of Latin American and Caribbean Countries) [PDF]
Kazakhstan [PDF]
Ukraine [PDF]

Agenda Item 4: International Patent System

Country/Observer Document(s)
Kazakhstan [PDF]

Agenda Item 5: Exceptions and limitations to patent rights

Draft reference document on the exception regarding private and/or non-commercial use (SCP/38/3)

Country/Observer Document(s)
Kazakhstan [PDF]
Japan Patent Attorneys Association (JPAA) [PDF]

Agenda Item 6: Quality of patents, including opposition systems

Update to document SCP/36/5 (SCP/38/4)

Country/Observer Document(s)
Kazakhstan [PDF]
Ukraine [PDF]
Japan Patent Attorneys Association (JPAA) [PDF]
Japan Intellectual Property Association (JIPA) [PDF]

Artificial Intelligence (AI) and Inventorship (Update of SCP/37/5) (SCP/38/5)

Country/Observer Document(s)
A contribution to the topic of AI and Inventorship from a group of interested Member States [PDF]
Japan Intellectual Property Association (JIPA) [PDF]

Report on expert exchange on legal and policy options in the areas of Patentability criteria and AI Inventorship (SCP/38/6)

Country/Observer Document(s)
Kazakhstan [PDF]
Kazakhstan [PDF]
Japan Patent Attorneys Association (JPAA) [PDF]

Proposal by the Delegation of China on information exchange concerning the protection of intellectual property in connection with outer space activities (SCP/38/10)

Country/Observer Document(s)
Kazakhstan [PDF]
Japan Patent Attorneys Association (JPAA) [PDF]

Agenda Item 7: Patents and health

Updates on the initiatives on publicly accessible databases of patent status information concerning medical products and health technologies

Country/Observer Document(s)
GRULAC (Group of Latin American and Caribbean Countries) [PDF]
Kazakhstan [PDF]
Japan Patent Attorneys Association (JPAA) [PDF]
Japan Intellectual Property Association (JIPA) [PDF]

Agenda Item 8: Confidentiality of communications between clients and their patent advisors

Study on the categories of professionals who enjoy protection against forcible disclosure of confidential communications between clients and their patent advisors in court proceedings under national/regional laws (SCP/38/7)

Country/Observer Document(s)
Kazakhstan [PDF]
Japan Patent Attorneys Association (JPAA) [PDF]

Agenda Item 9: Transfer of technology

Study on the determination of inventorship and conditions of foreign filing, with a view to identifying potential challenges for innovators in the cross-border collaborative environment (SCP/38/8)

Country/Observer Document(s)
Japan Patent Attorneys Association (JPAA) [PDF]

Study on best practices and challenges in technology transfer in the health and green technology sectors focusing on industry academia collaboration, considering national and international regulatory frameworks (SCP/38/9)

Country/Observer Document(s)
GRULAC (Group of Latin American and Caribbean Countries) [PDF]
Kazakhstan [PDF]
Japan Patent Attorneys Association (JPAA) [PDF]
Japan Intellectual Property Association (JIPA) [PDF]

Closing statements

Country/Observer Document(s)
GRULAC (Group of Latin American and Caribbean Countries) [PDF]

Inputs received from members and observers of the SCP in response to Circular C.9304

No. Country Inputs for the study on Conditions of Foreign Filing, and Challenges for Innovators in the Cross-Border Collaborative Environment (SCP/38/8) Inputs on other SCP documents Inputs on Certain Aspects of the Applicable National or Regional Patent Law (SCP/38/2) Inputs and updates to other webpages maintained by the SCP Secretariat
1 Algeria [PDF] (in French) [PDF] (in French)
2 Argentina [PDF] (in Spanish) [PDF] (in Spanish) [PDF] (in Spanish) [PDF] (in Spanish)
3 Armenia [PDF]
4 Australia [PDF] [PDF] [PDF] [PDF]
5 Belarus [PDF] [PDF] [PDF]
6 Bhutan [PDF]
7 Brazil [PDF] [PDF]
8 Brunei Darussalam [PDF]
9 Bulgaria [PDF] [PDF] [PDF] [PDF]
10 Burundi [PDF] (in French) [PDF] (in French)
11 Cambodia [PDF]
12 Canada [PDF] [PDF] [PDF] [PDF]
13 Chile [PDF] (in Spanish) [PDF] (in Spanish)
14 China [PDF] [PDF] [PDF] [PDF]
15 Colombia [PDF] (in Spanish) [PDF] (in Spanish)
16 Czech Republic [PDF] [PDF]
17 Ecuador [PDF] (in Spanish) [PDF] (in Spanish) [PDF] (in Spanish)
18 Egypt [PDF] [PDF 1] [PDF 2] [PDF]
19 El Salvador [PDF] (in Spanish) [PDF] (in Spanish)
20 Estonia [PDF] [PDF] [PDF] [PDF]
21 Finland [PDF]
22 France [PDF] (in French) [PDF] (in French) [PDF] (in French) [PDF] (in French)
23 Gambia (the) [PDF]
24 Georgia [PDF] [PDF] [PDF] [PDF]
25 Germany [PDF] [PDF]
26 Hungary [PDF] [PDF]
27 Ireland [PDF] [PDF]
28 Italy [PDF]
29 Japan [PDF] [PDF] [PDF] [PDF]
30 Lithuania [PDF]
31 Madagascar [PDF] (in French)
32 Malaysia [PDF] [PDF] [PDF]
33 Malta [PDF] [PDF]
34 Morocco [PDF] (in French) [PDF] (in French)
35 Namibia [PDF]
36 Norway [PDF]
37 Panama [PDF] (in Spanish)
38 Paraguay [PDF] (in Spanish)
39 Peru [PDF] (in Spanish)
40 Philippines [PDF]
41 Portugal [PDF] [PDF] [PDF] [PDF]
42 Republic of Korea [PDF] [PDF] [PDF]
43 Republic of Moldova [PDF] [PDF] [PDF] [PDF]
44 Singapore [PDF] [PDF] [PDF] [PDF]
45 Slovakia [PDF] [PDF] [PDF]
46 Slovenia [PDF 1] [PDF 2] [PDF 1] [PDF 2]
47 South Africa [PDF] [PDF]
48 Spain [PDF] (in Spanish) [PDF] (in Spanish) [PDF] (in Spanish)
49 Sweden [PDF] [PDF] [PDF]
50 Switzerland [PDF] [PDF] [PDF] [PDF]
51 Syrian Arab Republic [PDF] [PDF] [PDF] [PDF]
52 Trinidad and Tobago [PDF 1] [PDF 2]
53 Türkiye [PDF]
54 United Arab Emirates [PDF] [PDF]
55 United Republic of Tanzania [PDF] [PDF]
56 United States of America [PDF] [PDF]

Regional offices

No. Country Inputs for the study on Conditions of Foreign Filing, and Challenges for Innovators in the Cross-Border Collaborative Environment. (SCP/38/8) Inputs on other SCP documents Inputs on Certain Aspects of the Applicable National or Regional Patent Law. (SCP/38/2) Inputs and updates to other webpages maintained by the SCP Secretariat.
1 ARIPO [PDF]
2 Eurasian Patent Office (EAPO) [PDF] [PDF]
3 European Patent Office (EPO) [PDF] [PDF] [PDF]
4 GCC Patent Office [PDF]

Quality of patents, including opposition systems (agenda item Y)

Country/Observer Document(s)
Country name [PDF]
Country name [PDF]
Country name [PDF]

Closing statements

Country/Regional Group Document(s)
Country name [PDF]